2022
DOI: 10.1007/s00705-022-05466-y
|View full text |Cite
|
Sign up to set email alerts
|

Role of plasmatic and urinary concentration of tenofovir disoproxil fumarate in a cohort of patients affected by chronic hepatitis B

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…Tenofovir plasmatic concentration has a high predictive value in monitoring the prevention of HIV infection by TDF, and different concentrations have different protection rates against HIV [ 68 ]. In addition, the monitoring of plasmatic and urinary drug concentrations of TDF has a certain reference value for the clinical treatment of CHB patients [ 69 ]. It can be seen that the treatment effect on HIV and CHB patients can be predicted by measuring the concentration of TDF in serum and urine.…”
Section: Resultsmentioning
confidence: 99%
“…Tenofovir plasmatic concentration has a high predictive value in monitoring the prevention of HIV infection by TDF, and different concentrations have different protection rates against HIV [ 68 ]. In addition, the monitoring of plasmatic and urinary drug concentrations of TDF has a certain reference value for the clinical treatment of CHB patients [ 69 ]. It can be seen that the treatment effect on HIV and CHB patients can be predicted by measuring the concentration of TDF in serum and urine.…”
Section: Resultsmentioning
confidence: 99%